[1]黄凤连,杨俊朋,史晓阳,等.肠道菌群与糖尿病自主神经病变关系的研究进展[J].国际内分泌代谢杂志,2023,43(01):18-21.[doi:10.3760/cma.j.cn121383-20211106-11018]
　Huang Fenglian,Yang Junpeng,Shi Xiaoyang,et al.Research progress on the relationship between gut microbiota and diabetic autonomic neuropathy[J].International Journal of Endocrinology and Metabolism,2023,43(01):18-21.[doi:10.3760/cma.j.cn121383-20211106-11018]
点击复制

肠道菌群与糖尿病自主神经病变关系的研究进展()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
43
期数:
2023年01期
页码:
18-21
栏目:
肠道菌群与代谢性疾病专题
出版日期:
2023-01-20

文章信息/Info

Title:
Research progress on the relationship between gut microbiota and diabetic autonomic neuropathy
作者:
黄凤连1; 2; 杨俊朋2; 史晓阳2; 王秀丹2; 袁慧娟2
1新乡医学院,新乡 453003; 2河南省人民医院内分泌与代谢病科,郑州 450003
Author(s):
Huang Fenglian1; 2;  Yang Junpeng2;  Shi Xiaoyang2;  Wang Xiudan2;  Yuan Huijuan2.
1Xinxiang Medical University, Xinxiang 453003, China; Department of Endocrinology and Metabolic Diseases, Henan Provincial People's Hospital, Zhengzhou 450003, China
关键词:
糖尿病;  肠道菌群;  自主神经病变;  糖尿病自主神经病变
Keywords:
Diabetes mellitus;  Gut microbiota;  Autonomic neuropathy;  Diabetic autonomic neuropathy
DOI:
10.3760/cma.j.cn121383-20211106-11018
摘要:
糖尿病自主神经病变是糖尿病常见并发症,具有治疗难度大、预后差及死亡率高的特征,可对患者的生活、工作产生深远影响,故糖尿病自主神经的防治已愈加受到临床重视。肠道菌群作为一种环境因素,与糖尿病自主神经病变的发生发展有着密切关系,影响着糖尿病自主神经病变的预后。因此,探究肠道菌群及其代谢物在糖尿病自主神经病变中的作用将有助于阐明糖尿病自主神经病变的发病机制,并为其预防和治疗提供新的思路和靶点。
Abstract:
Diabetic autonomic neuropathy is a common complication of diabetes, which is characterized by difficult treatment, poor prognosis and high mortality. It can exert a profound influence on the life and work of patients. Therefore, the prevention and treatment of diabetic autonomic neuropathy has been paid more and more clinical attention. As an environmental factor, gut microbiota is closely related to the occurrence and development of diabetic autonomic neuropathy, and affects the prognosis of diabetic autonomic neuropathy. Therefore, exploring the role of gut microbiota and its metabolites in diabetic autonomic neuropathy will help clarify the pathogenesis of diabetic autonomic neuropathy, and provide new ideas and targets for its prevention and treatment

参考文献/References:

[1] Ma Q,Xing C,Long W,et al.Impact of microbiota on central nervous system and neurological diseases:the gut-brain axis[J].J Neuroinflammation,2019,16(1):53.DOI:10.1186/s12974-019-1434-3.
[2] Bhattarai Y.Microbiota-gut-brain axis:interaction of gut microbes and their metabolites with host epithelial barriers[J].Neurogastroenterol Motil,2018,30(6):e13366.DOI:10.1111/nmo.13366.
[3] 何天祎.SUDOSCAN筛查社区居民心血管自主神经病变与预测不良结局的相关研究[D].山东:山东大学,2018:1-150.
[4] Meng G,Zhou X,Wang M,et al.Gut microbe-derived metabolite trimethylamine N-oxide activates the cardiac autonomic nervous system and facilitates ischemia-induced ventricular arrhythmia via two different pathways[J].EBioMedicine,2019,44:656-664.DOI:10.1016/j.ebiom.2019.03.066.
[5] Tang WH,Kitai T,Hazen SL.Gut Microbiota in Cardiovascular Health and Disease[J].Circ Res,2017,120(7):1183-1196.DOI:10.1161/CIRCRESAHA.117.309715.
[6] Wu C,Pan LL,Niu W,et al.Modulation of gut microbiota by low methoxyl pectin attenuates type 1 diabetes in non-obese diabetic mice[J].Front Immunol,2019,10:1733.DOI:10.3389/fimmu.2019.01733.
[7] Leustean AM,Ciocoiu M,Sava A,et al.Implications of the intestinal microbiota in diagnosing the progression of diabetes and the presence of cardiovascular complications[J].J Diabetes Res,2018,2018:5205126.DOI:10.1155/2018/5205126.
[8] Zhao L,Zhang F,Ding X,et al.Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes[J].Science,2018,359(6380):1151-1156.DOI:10.1126/science.aao5774.
[9] Duscha A,Gisevius B,Hirschberg S,et al.Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism[J].Cell,2020,180(6):1067-1080.e16.DOI:10.1016/j.cell.2020.02.035.
[10] Tolhurst G,Heffron H,Lam YS,et al.Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2[J].Diabetes,2012,61(2):364-371.DOI:10.2337/db11-1019.
[11] Grasset E,Puel A,Charpentier J,et al.Gut microbiota dysbiosis of type 2 diabetic mice impairs the intestinal daily rhythms of GLP-1 sensitivity[J]. Acta Diabetol,2022,59(2):243-258.DOI:10.1007/s00592-021-01790-y.
[12] Du Y,Neng Q,Li Y,et al.Gastrointestinal Autonomic Neuropathy Exacerbates Gut Microbiota Dysbiosis in Adult Patients With Type 2 Diabetes Mellitus[J].Front Cell Infect Microbiol,2022,11:804733.DOI:10.3389/fcimb.2021.804733.
[13] Nyavor Y,Brands CR,May G,et al.High-fat diet-induced alterations to gut microbiota and gut-derived lipoteichoic acid contributes to the development of enteric neuropathy[J].Neurogastroenterol Motil,2020,32(7):e13838.DOI:10.1111/nmo.13838.
[14] 汪晶美,杨云梅.老年2型糖尿病合并胃轻瘫患者的肠道菌群分析[J].中华危重症医学杂志,2020,13(2):106-112.DOI:10.3877/cma.j.issn.1674-6880.2020.02.006.
[15] Perry RJ,Peng L,Barry NA,et al.Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome[J].Nature, 2016,534(7606):213-217.DOI:10.1038/nature18309.
[16] Amato A,Cinci L,Rotondo A,et al.Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors[J].Neurogastroenterol Motil,2010,22(6):664-e203.DOI:10.1111/j.1365-2982.2010.01476.x.
[17] Linetzky Waitzberg D,Alves Pereira CC,Logullo L,et al.Microbiota benefits after inulin and partially hydrolized guar gum supplementation:a randomized clinical trial in constipated women[J].Nutr Hosp,2012,27(1):123-129.DOI:10.1590/S0212-16112012000100014.
[18] Nozu T,Miyagishi S,Nozu R,et al.Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome[J].Sci Rep,2019,9(1):19603.DOI:10.1038/s41598-019-56132-4.
[19] 邹瑞政,刘畅,王俊等.红霉素治疗糖尿病胃轻瘫对肠道菌群及循环炎性因子的影响[J].重庆医学,2016,45(4):478-480.DOI:10.3969/j.issn.1671-8348.2016.04.016.
[20] Martin AM,Young RL,Leong L,et al.The diverse metabolic roles of peripheral serotonin[J].Endocrinology,2017,158(5):1049-1063.DOI:10.1210/en.2016-1839.
[21] Lane-Cordova AD,Kershaw K,Liu K,et al.Association between cardiovascular health and endothelial function with future erectile dysfunction:the multi-ethnic study of atherosclerosis[J].Am J Hypertens,2017,30(8):815-821.DOI:10.1093/ajh/hpx060.
[22] Li H,Qi T,Huang ZS,et al.Relationship between gut microbiota and type 2 diabetic erectile dysfunction in Sprague-Dawley rats[J].J Huazhong Univ Sci Technolog Med Sci,2017,37(4):523-530.DOI:10.1007/s11596-017-1767-z.
[23] Seldin MM,Meng Y,Qi H,et al.Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-κB[J].J Am Heart Assoc,2016,5(2):e002767.DOI:10.1161/JAHA.115.002767.
[24] Tenore GC,Caruso D,Buonomo G,et al.Lactofermented annurca apple puree as a functional food indicated for the control of plasma lipid and oxidative amine levels:results from a randomised clinical trial[J].Nutrients,2019,11(1):122.DOI:10.3390/nu11010122.
[25] Colldén H,Landin A,Wallenius V,et al.The gut microbiota is a major regulator of androgen metabolism in intestinal contents[J].Am J Physiol Endocrinol Metab,2019,317(6):E1182-E1192.DOI:10.1152/ajpendo.00338.2019.
[26] Beli E,Yan Y,MoldovanL,et al.Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db/db mice[J].Diabetes,2018,67(9):1867-1879.DOI:10.2337/db18-0158.

相似文献/References:

[1]郑少雄.罗格列酮和心血管风险——近期文献解读[J].国际内分泌代谢杂志,2007,(04):231.
[2]凌厉,朱本章.胰岛素类似物安全性研究进展[J].国际内分泌代谢杂志,2007,(04):234.
[3]李颖,刘东方.餐后1小时血糖升高的意义及干预[J].国际内分泌代谢杂志,2007,(04):235.
[4]崔巍,施秉银.内质网应激介导β细胞生存/死亡的研究进展[J].国际内分泌代谢杂志,2007,(04):256.
[5]杨叶虹,胡仁明.SELDI-TOF-MS技术及其在糖尿病研究中的应用[J].国际内分泌代谢杂志,2007,(04):261.
[6]高妍.针对华人糖尿病特点优化降糖方案[J].国际内分泌代谢杂志,2007,(04):269.
[7]杨志霞,郭莹辉,杨永生,等.胰岛素泵和多次皮下注射治疗糖尿病的比较[J].国际内分泌代谢杂志,2007,(04):273.
[8]周建英,马向华.胃旁路术减肥同时改善糖代谢的机制[J].国际内分泌代谢杂志,2007,(04):285.
[9]李翠柳,朱大龙.破译肠道代谢信息,驱动治疗革新[J].国际内分泌代谢杂志,2014,(06):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
　Li Cuiliu*,Zhu Dalong..Deciphering metabolic messages from the gut drives therapeutic innovation[J].International Journal of Endocrinology and Metabolism,2014,(01):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
[10]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
　Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(01):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]

备注/Memo

备注/Memo:
通信作者:袁慧娟,Emali:hjyuan@zzu.edu.cn
基金项目:国家自然科学基金(81970705); 中原千人计划-中原科技创新领军人才(204200510026); 河南省2020年中医药科学研究专项课题(20-21ZY2304); 2020年河南省医学科技攻关计划省部共建青年项目(SBGJ202003007)
更新日期/Last Update: 2023-01-30